Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-12 Option Award(A) |
2022-01-13 4:21 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer |
26,471 | $0 | 26,471 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:19 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer |
26,471 | $0 | 26,471 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:15 pm |
N/A 2032-01-10 |
CinCor Pharma Inc. | CINC | Lee June Director |
47,954 | $0 | 47,954 (Direct) |
View |
Ownership |
2022-01-10 4:12 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | CinRx Pharma LLC 10% Owner |
0 | $0 | 3,630,103 (Direct) |
View |
Ownership |
2022-01-06 9:04 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | General Atlantic (CIN) L.P. GAP COINVESTMENTS III LLC GAP COINVESTMENTS IV LLC GAP Coinvestments V LLC GAP Coinvestments CDA L.P. 10% Owner |
0 | $0 | 2,426,470 (Indirect) |
View |
Ownership |
2022-01-06 9:03 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | GENERAL ATLANTIC L.P. GAP (Bermuda) L.P. GENERAL ATLANTIC GENPAR (BERMUDA) L.P. General Atlantic (Lux) S.a r.l. General Atlantic GenPar (Lux) SCSp General Atlantic Partners (Lux) SCSp General Atlantic Partners 100 L.P. GENERAL ATLANTIC GENPAR L.P. General Atlantic Partners (Bermuda) EU L.P. General Atlantic (SPV) GP LLC 10% Owner |
0 | $0 | 2,426,470 (Indirect) |
View |
Ownership |
2022-01-06 9:02 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner |
0 | $0 | 3,867,646 (Indirect) |
View |
Ownership |
2022-01-06 9:00 pm |
N/A 2031-06-17 |
CinCor Pharma Inc. | CINC | THERO JOHN F Director |
0 | $0 | 95,147 (Direct) |
View |
Ownership |
2022-01-06 8:57 pm |
N/A 2031-06-17 |
CinCor Pharma Inc. | CINC | Ignelzi Troy A. Director |
0 | $0 | 95,147 (Direct) |
View |
Ownership |
2022-01-06 8:56 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Sofinnova Partners SAS Sofinnova Capital IX 10% Owner |
0 | $0 | 3,867,646 (Indirect) |
View |
Ownership |
2022-01-06 8:54 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Katabi Maha Sofinnova Management X L.L.C. 10% Owner |
0 | $0 | 5,248,949 (Indirect) |
View |
Ownership |
2022-01-06 8:53 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | HEALY JAMES Director 10% Owner |
0 | $0 | 5,278,360 (Indirect) |
View |
Ownership |
2022-01-06 8:51 pm |
N/A 2031-12-09 |
CinCor Pharma Inc. | CINC | Allison David D. Director |
0 | $0 | 29,411 (Direct) |
View |
Ownership |
2022-01-06 8:49 pm |
N/A 2029-09-24 |
CinCor Pharma Inc. | CINC | Freeman Mason EVP Clinical Development |
0 | $0 | 295,854 (Direct) |
View |
Ownership |
2022-01-06 8:48 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer |
0 | $0 | 240,297 (Direct) |
View |
Ownership |
2022-01-06 8:47 pm |
N/A 2031-11-03 |
CinCor Pharma Inc. | CINC | Coelho Mary Theresa EVP CFO & Chief BD Officer |
0 | $0 | 354,154 (Direct) |
View |
Ownership |
2022-01-06 8:46 pm |
N/A 2031-06-17 |
CinCor Pharma Inc. | CINC | de Garidel Marc Chief Executive Officer |
0 | $0 | 1,328,384 (Direct) |
View |